NCT00047658View on ClinicalTrials.gov

A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2001

Study Completion Date

May 31, 2003

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Interferon-gamma 1b

200 mcg, SQ, 3x per week

Trial Locations (1)

90095

UCLA, Dept. of Medicine, Los Angeles

Sponsors

Lead Sponsor

InterMune
All Listed Sponsors
lead

InterMune

INDUSTRY